(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.

Por Zenklusen, J C, Bièche, I, Lidereau, R, Conti, C J
Publicado em 1994

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays

Por Bièche, I, Olivi, M, Noguès, C, Vidaud, M, Lidereau, R
Publicado em 2002

KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition

Por Rouleau, E, Spyratos, F, Dieumegard, B, Guinebretière, J M, Lidereau, R, Bièche, I
Publicado em 2008

Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas

Por Bièche, I, Girault, I, Sabourin, J-C, Tozlu, S, Driouch, K, Vidaud, M, Lidereau, R
Publicado em 2003

Overexpression of the stathmin gene in a subset of human breast cancer.

Por Bièche, I., Lachkar, S., Becette, V., Cifuentes-Diaz, C., Sobel, A., Lidereau, R., Curmi, P. A.
Publicado em 1998

Gene expression and hepatitis C virus infection

Por Asselah, T, Bièche, I, Sabbagh, A, Bedossa, P, Moreau, R, Valla, D, Vidaud, M, Marcellin, P
Publicado em 2009

Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers

Por Dickinson, R E, Dallol, A, Bieche, I, Krex, D, Morton, D, Maher, E R, Latif, F
Publicado em 2004

Hedgehog pathway activation in human transitional cell carcinoma of the bladder

Por Pignot, G, Vieillefond, A, Vacher, S, Zerbib, M, Debre, B, Lidereau, R, Amsellem-Ouazana, D, Bieche, I
Publicado em 2012

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours

Por Curmi, P A, Noguès, C, Lachkar, S, Carelle, N, Gonthier, M-P, Sobel, A, Lidereau, R, Bièche, I
Publicado em 2000

Single agent and combination studies of pralatrexate and molecular correlates of sensitivity

Por Serova, M, Bieche, I, Sablin, M-P, Pronk, G J, Vidaud, M, Cvitkovic, E, Faivre, S, Raymond, E
Publicado em 2011

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels

Por Rondeau, S, Vacher, S, De Koning, L, Briaux, A, Schnitzler, A, Chemlali, W, Callens, C, Lidereau, R, Bièche, I
Publicado no Br J Cancer (2015)

CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients

Por Lefort, S, Thuleau, A, Kieffer, Y, Sirven, P, Bieche, I, Marangoni, E, Vincent-Salomon, A, Mechta-Grigoriou, F
Publicado no Oncogene (2017)

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours

Por Cooper, WN, Dickinson, RE, Dallol, A, Hesson, LB, Bieche, I, Clark, GJ, Maher, ER, Zabarovsky, ER, Latif, F
Publicado em 2008

Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease

Por Paradis, V, Bièche, I, Dargère, D, Cazals-Hatem, D, Laurendeau, I, Saada, V, Belghiti, J, Bezeaud, A, Vidaud, M, Bedossa, P, Valla, D-C
Publicado em 2005

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab

Por Cizkova, M, Dujaric, M-E, Lehmann-Che, J, Scott, V, Tembo, O, Asselain, B, Pierga, J-Y, Marty, M, de Cremoux, P, Spyratos, F, Bieche, I
Publicado em 2013

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation

Por Weiswald, L-B, Richon, S, Massonnet, G, Guinebretière, J-M, Vacher, S, Laurendeau, I, Cottu, P, Marangoni, E, Nemati, F, Validire, P, Bellet, D, Bièche, I, Dangles-Marie, V
Publicado em 2013

Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness

Por Weiswald, L-B, Richon, S, Validire, P, Briffod, M, Lai-Kuen, R, Cordelières, F P, Bertrand, F, Dargere, D, Massonnet, G, Marangoni, E, Gayet, B, Pocard, M, Bieche, I, Poupon, M-F, Bellet, D, Dangles-Marie, V
Publicado em 2009

Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients

Por Olivier, M, Langerød, A, Carrieri, P, Bergh, J, Klaar, S, Eyfjord, J, Theillet, C, Rodriguez, C, Lidereau, R, Bièche, I, Varley, J, Bignon, Y, Uhrhammer, N, Winqvist, R, Jukkola-Vuorinen, A, Niederacher, D, Kato, S, Ishioka, C, Hainaut, P, Børresen-Dale, A-L
Publicado no Breast Cancer Res (2005)

A refined molecular taxonomy of breast cancer

Por Guedj, M, Marisa, L, de Reynies, A, Orsetti, B, Schiappa, R, Bibeau, F, MacGrogan, G, Lerebours, F, Finetti, P, Longy, M, Bertheau, P, Bertrand, F, Bonnet, F, Martin, A L, Feugeas, J P, Bièche, I, Lehmann-Che, J, Lidereau, R, Birnbaum, D, Bertucci, F, de Thé, H, Theillet, C
Publicado em 2012

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Por Beau-Faller, M., Prim, N., Ruppert, A.-M., Nanni-Metéllus, I., Lacave, R., Lacroix, L., Escande, F., Lizard, S., Pretet, J.-L., Rouquette, I., de Crémoux, P., Solassol, J., de Fraipont, F., Bièche, I., Cayre, A., Favre-Guillevin, E., Tomasini, P., Wislez, M., Besse, B., Legrain, M., Voegeli, A.-C., Baudrin, L., Morin, F., Zalcman, G., Quoix, E., Blons, H., Cadranel, J.
Publicado em 2014